SCHEMBL4181687

SCHEMBL4181687

COc1ccc2oc(C(=O)C(C)(C)C)c(CC(C)(C)C(C)=O)c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.48
SMN1; SMN2 Q16637 10/20 0.48
ALDH1A1 P00352 9/20 0.48
NPC1 O15118 7/20 0.48
RAB9A P51151 7/20 0.48
HSD17B10 Q99714 4/20 0.46
HPGD P15428 4/20 0.46
TP53 P04637 1/20 0.46
HTT P42858 1/20 0.46
MAPT P10636 4/20 0.44
MEN1 O00255 1/20 0.44
LMNA P02545 1/20 0.44
KMT2A Q03164 1/20 0.44
NQO1 P15559 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
MTNR1A P48039 4/20 0.43
MTNR1B P49286 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4193683 0.88 KDM4E (0.46) KDM4ESMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL4187070 0.83 KDM4E (0.52) KDM4ESMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL4181685 0.83 KDM4E (0.50) KDM4ESMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL4193680 0.81 KDM4E (0.46) KDM4ESMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL4187152 0.80 KDM4E (0.47) KDM4ESMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL4179939 0.78 RAB9A (0.70) KDM4ESMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL4196169 0.77 KDM4E (0.45) KDM4ESMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL4191372 0.77 KDM4E (0.52) KDM4ESMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL4486505 0.77 MTNR1A (0.49) KDM4ESMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL4191948 0.77 MEN1 (0.45) KDM4ESMN1; SMN2ALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1664011-A4 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO INC (US) 2009-02-25 EP claimed
EP-1664011-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION Merck & Co., Inc. (US) 2006-06-07 EP claimed
WO-2005020917-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO., INC. (US) 2005-03-10 WO claimed
EP-1664011-A4 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO INC (US) 2009-02-25 EP disclosed
EP-1664011-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION Merck & Co., Inc. (US) 2006-06-07 EP disclosed
WO-2005020917-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO., INC. (US) 2005-03-10 WO disclosed